InvestorsHub Logo
icon url

exwannabe

07/23/18 5:03 PM

#183761 RE: sentiment_stocks #183757

Why do you focus on safety or efficacy when it wasn't initially needed?


It was not needed for the import/export license.

Why would anybody think it would not be needed for commercial use?

Why would anbody think establishing safety and efficacy is a simple issue for drug approval?

How the hell would it ever be possible for any LEGIT drug manufacture not to udnerstand that safety anf effacy is the key issue and often VERY difficult to prove?
icon url

exwannabe

02/25/24 6:41 AM

#674507 RE: sentiment_stocks #183757

I see you are spinning this crap again,.

NWBO was forced to put out a retraction just a week later saying how some may have been confused by the first PR to think that the -L was actually available. Really? Was it the lawsuit or the SEC letter that caused LP to react?

How confused was Nevid Malik who was all over the place pumping the "first commercially approved oncology vaccine", and patients flocking from all over Europe to get it?

How many shares did he manage to sell to fools who bought in at a price that has no chance to even be seen again? Sure, some got money back by the lawsuit, but NWBO was to broke to really cough up much so the settlement was minor.

I like the way LP never keeps much cash in NWBO. Makes lawsuits kind of pointless.